Source: NASDAQ Stocks / 04 Jan 2025 13:48:21 America/Chicago
Fintel reports that on January 3, 2025, Guggenheim downgraded their outlook for ACADIA Pharmaceuticals (LSE:0A4W) from Buy to Neutral.
https://www.nasdaq.com/articles/guggenheim-downgrades-acadia-pharmaceuticals-lse-0a4w